Corpus ID: 55350621

Scrambler (Calmare) Therapy for Intractable Chronic Pain

  title={Scrambler (Calmare) Therapy for Intractable Chronic Pain},
  author={Soo A Kim},
Intractable chronic pain is a debilitative pain conditions for most patients. Unfortunately, the pain control managements currently have shown that it is not appropriate to reduce pain and limited efficacy and sometimes unfavorable in some patients. Scrambler (Calmare) therapy, used as an alternative treatment for chronic neuropathic pain recently, is a noninvasive approach to relieve pain by changing pain perception. The author reports the clinical experiences on effectiveness of Scrambler… Expand
1 Citations

Figures from this paper

Inside the Scrambler Therapy, a Noninvasive Treatment of Chronic Neuropathic and Cancer Pain: From the Gate Control Theory to the Active Principle of Information
  • G. Marineo
  • Medicine
  • Integrative cancer therapies
  • 2019
The aim of this review is to clarify the underlying theory of Scramblers Therapy and describe the appropriate usage method that maximizes its effectiveness while reducing bias and deepen the explanation of the artificial neuron technology associated with Scrambler Therapy. Expand


Clinical Experiences on the Effect of Scrambler Therapy for Patients with Postherpetic Neuralgia
Scrambler Therapy, proposed as an alternative treatment for chronic neuropathic pain recently, is a noninvasive approach to relieve pain by changing pain perception at the brain level. Expand
Scrambler Therapy for Patients with Cancer Pain - Case Series -
Scrambler therapy synthesizes 16 different types of nerve action potentials that provide "non-pain" information via cutaneous nerves that is non-invasive and safe and has no significant side effects in patients with intractable pain. Expand
Scrambler therapy may relieve chronic neuropathic pain more effectively than guideline-based drug management: results of a pilot, randomized, controlled trial.
In this pilot randomized trial, Scrambler therapy appeared to relieve chronic neuropathic pain better than guideline-based drug management. Expand
A Trial of Scrambler Therapy in the Treatment of Cancer Pain Syndromes and Chronic Chemotherapy-Induced Peripheral Neuropathy
Clinically important and statistically significant improvements were seen in average, least, and worst pain; BPI interference with life scores, and motor and sensory scales on the EORTC CIPN-20. Expand
Untreatable pain resulting from abdominal cancer: new hope from biophysics?
  • G. Marineo
  • Medicine
  • JOP : Journal of the pancreas
  • 2003
The preliminary results obtained using scrambler therapy are extremely encouraging, both in terms of enhanced pain control after each treatment session and in view of the possible maintenance of effectiveness over time. Expand
Scrambler therapy.
Evaluating the effectiveness of ST5 in the treatment of neuropathic pain found that it produced a statistically significant (P<0.0001) pain relief in all treated neuropathies. Expand
Pilot evaluation of Scrambler therapy for the treatment of chemotherapy-induced peripheral neuropathy
Preliminary data support that Scrambler therapy may be effective for the treatment of CIPN: a prospective placebo-controlled clinical trial should be performed. Expand
Decreased low back pain intensity and differential gene expression following Calmare®: results from a double-blinded randomized sham-controlled study.
There were significant differences in pain sensitivity and differential mRNA expression of 17 pain genes, suggesting that Calmare® can be effective in reducing pain intensity and interference in individuals with persistent low back pain by altering the mechanisms of enhanced pain sensitivity. Expand
Therapeutic Strategies for Cancer Treatment Related Peripheral Neuropathies
Duloxetine, a serotonin-norepinephrine reuptake inhibitor, has the most evidence supporting its use in the treatment of CIPN, and nonpharmacologic interventions including acupuncture and Scrambler therapy are supported by positive preliminary data; however, further larger, placebo-controlled trial data are needed to confirm or refute their effectiveness. Expand